Zobrazeno 1 - 10
of 439
pro vyhledávání: '"Jose A Karam"'
Publikováno v:
Indian Journal of Urology, Vol 37, Iss 1, Pp 13-16 (2021)
The management of metastatic renal cell carcinoma (mRCC) continues to be a therapeutic challenge; however, the options for systemic therapy in this setting have exploded over the past 20 years. From the advent of toxic cytokine therapy to the subsequ
Externí odkaz:
https://doaj.org/article/534d2f55a2464700a006cefb93ce1998
Autor:
Yohei Sekino, Naoya Sakamoto, Keisuke Goto, Ririno Honma, Yoshinori Shigematsu, Thang Pham Quoc, Kazuhiro Sentani, Naohide Oue, Jun Teishima, Fumi Kawakami, Jose A Karam, Kanishka Sircar, Akio Matsubara, Wataru Yasui
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background The transcribed ultraconserved regions (T-UCRs) are a novel class of non-coding RNAs that are absolutely conserved across species and are involved in carcinogenesis in some cancers. However, the expression and biological role of T
Externí odkaz:
https://doaj.org/article/c06d0c9c23814404a6656c88a4d35716
Autor:
Jose A. Karam, Rituparna Bhattacharya, Adesuwa Ogbomo, Santosh Gautam, Rebekah Yu, Murali Sundaram, Kentaro Imai, Jatin Chhabra, Naomi B. Haas
Publikováno v:
Cancer Medicine, Vol 13, Iss 11, Pp n/a-n/a (2024)
Abstract Objectives To examine real‐world characteristics, journey, and outcomes among patients with locoregional, nonmetastatic renal cell carcinoma (RCC). Methods A retrospective analysis of medical records from the ConcertAI Oncology Dataset was
Externí odkaz:
https://doaj.org/article/114a798ad53a40e3af83b84a005b366d
Autor:
Philippe E. Spiess, Scott Delacroix, Brian F. Chapin, Vitaly Margulis, Edwin Jason Abel, Jose A. Karam
Publikováno v:
Société Internationale d’Urologie Journal, Vol 5, Iss 1, Pp 4-6 (2024)
Dr [...]
Externí odkaz:
https://doaj.org/article/08e8c7f3784e40afa57f108618bd3feb
Autor:
Matthew T. Campbell, Surena F. Matin, Alda L. Tam, Rahul A. Sheth, Kamran Ahrar, Rebecca S. Tidwell, Priya Rao, Jose A. Karam, Christopher G. Wood, Nizar M. Tannir, Eric Jonasch, Jianjun Gao, Amado J. Zurita, Amishi Y. Shah, Sonali Jindal, Fei Duan, Sreyashi Basu, Hong Chen, Alexsandra B. Espejo, James P. Allison, Shalini S. Yadav, Padmanee Sharma
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Anti-CTLA4 therapy has not been comprehensively explored for the treatment of metastatic renal cell carcinoma (mRCC). Here, in a pilot study of anti-CTLA4 therapy with or without cryoablation in mRCC, the authors report that the combination is feasib
Externí odkaz:
https://doaj.org/article/204efb116032411484ebc80c52f409dc
Autor:
Daniel D. Shapiro, Jose A. Karam, Logan Zemp, Viraj A. Master, Wade J. Sexton, Ali Ghasemzadeh, Benjamin N. Schmeusser, Facundo Davaro, Taylor Peak, Dattatraya Patil, Surena Matin, Philippe E. Spiess, E. Jason Abel
Publikováno v:
European Urology Open Science. 50:43-46
Autor:
Alberto C. Pieretti, Manuel Ozambela, Mary E. Westerman, Graciela M. Nogueras-Gonzalez, Luis A. Segarra, Niki M. Zacharias, Ara Vaporciyan, Wayne Hofstetter, Tam Huynh, Saad Aldousari, Surena F. Matin, Jose A. Karam
Publikováno v:
Clinical Genitourinary Cancer. 20:e330-e338
Surgical resection of renal cell carcinoma (RCC) with inferior vena cava (IVC) thrombus is a complex procedure with significant morbidity. Patient selection is critical to determining whether the benefits of the procedure outweigh the risks. In this
Autor:
Jose A. Karam, Pavlos Msaouel, Cara L. Haymaker, Surena F. Matin, Matthew T. Campbell, Amado J. Zurita, Amishi Y. Shah, Ignacio I. Wistuba, Enrica Marmonti, Dzifa Y. Duose, Edwin R. Parra, Luisa Maren Solis Soto, Caddie Laberiano-Fernandez, Marisa Lozano, Alice Abraham, Max Hallin, Curtis D. Chin, Peter Olson, Hirak Der-Torossian, Xiaohong Yan, Nizar M. Tannir, Christopher G. Wood
Publikováno v:
Nature Communications. 14
Sitravatinib is an immunomodulatory tyrosine kinase inhibitor that can augment responses when combined with programmed death-1 inhibitors such as nivolumab. We report a single-arm, interventional, phase 2 study of neoadjuvant sitravatinib in combinat
Autor:
Daniel D. Shapiro, Niki Millward Zacharias, Durga N. Tripathi, Menuka Karki, Jean‐Philippe Bertocchio, Melinda Soeung, Rong He, Mary E. Westerman, Jianjun Gao, Priya Rao, Truong N. A. Lam, Eric Jonasch, Luigi Perelli, Emily H. Cheng, Alessandro Carugo, Timothy P. Heffernan, Cheryl L. Walker, Giannicola Genovese, Nizar M. Tannir, Jose A. Karam, Pavlos Msaouel
Publikováno v:
Clinical and Translational Medicine. 13
Autor:
Joseph A. Moore, Michael J. Lehner, Simone Anfossi, Saumil Datar, Rebecca S. Tidwell, Matthew Campbell, Amishi Y. Shah, John F. Ward, Jose A. Karam, Christopher G. Wood, Lois L. Pisters, George A. Calin, Shi‐Ming Tu
Publikováno v:
BJUI Compass. 4:81-87
To investigate the utility of a novel serum miRNA biomarker panel to distinguish teratoma from nonmalignant necrotic/fibrotic tissues or nonviable tumours in patients with NSGCT undergoing post-chemotherapy consolidation surgery.We prospectively coll